Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Supplemental
Segments

Unit Economics
Common Size IS
Op Efficiency
Credit Analysis

LIGAND PHARMACEUTICALS INC (LGND)

Balance Sheet

Standardized | As Reported Annual | Quarterly
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   8-K10-K10-K10-K10-K10-K10-K10-K
Assets  
Cash and equivalents  211.919.547.671.5117.220.618.897.4
Short-term investments   321.6363.6998.3601.2181.0122.3102.8
Accounts receivable, net  30.485.556.830.455.925.614.76.2
Inventories  13.327.326.57.37.14.41.91.6
Other current assets  8.010.96.016.189.25.45.46.7
Total current assets  263.6464.8500.61,123.6870.5237.0163.1214.7
Property, plant, and equipment, net   20.514.47.25.44.21.80.4
Intangibles   551.0595.3210.4219.8228.6204.748.3
Goodwill   181.2189.795.286.686.072.212.2
Other fixed assets   2.74.32.30.54.91.70.0
Total assets  762.71,297.61,362.31,494.91,260.8671.0601.6503.1
   
Accounts payable   8.43.82.44.22.32.74.1
Accrued expenses   17.618.58.619.27.46.45.4
Short-term and curr portion of long-term debt   [+]0.00.00.00.026.4224.5425.8404.0
Other current liabilities  98.815.777.86.032.44.7-207.8-190.6
Total current liabilities  98.841.7100.117.082.2238.9227.1222.8
Long-term debt   320.7442.3639.0609.9   
Other liabilities  66.4114.0110.471.77.813.53.63.3
Total liabilities  165.2476.4652.8727.7699.9252.4230.7226.2
   
Shareholders' equity   [+]597.5821.2709.5767.2560.9418.6370.9276.9
Tangible shareholders' equity  597.588.9-75.5461.6254.5104.193.9216.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy